Strong sales performance in the first nine months of 2010/11

Press release -

Strong sales performance in the first nine months of 2010/11

Continued solid performance in Q3 leads to an upgrade of expectations to the organic revenue growth for 2010/11.

“With year-to-date revenue growth of 19%, 16% organic growth, EBIT growth of 18% and a solid operating profit margin of 24% Chr. Hansen continues to deliver a strong performance. Organic growth for the group remained strong in Q3. Driven by the continued move from synthetic to natural colors, the Natural Colors Division once again delivered a strong performance, while organic growth in the Cultures & Enzymes Division was more modest,” says CEO Lars Frederiksen.

“Based on the continued momentum in the Natural Colors Division, we have upgraded our expectations to the organic revenue growth for the full year from 12-14% to 14-15%. As a result of scalability effects in all divisions and a continued efficiency focus, operating profit (EBIT) margin before special items is still expected to be at or above 25%, despite the increased pressure from the changed business mix.”

Highlights

  • Revenue in the first nine months of 2010/11 amounted to EUR 474 million, up 19%´
  • Organic revenue growth of 16% for the first nine months of 2010/11
  • Operating profit (EBIT) before special items up by 18% to EUR 113 million
  • In Q3 2010/11 revenue increased by 11% corresponding to an organic revenue growth of 12
  • Operating profit margin (EBIT) before special items reached 26% in Q3


Please see the interim report for further details.

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen